Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Verastem Inc (VSTM)

Verastem Inc (VSTM)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 488,047
  • Shares Outstanding, K 180,758
  • Annual Sales, $ 88,520 K
  • Annual Income, $ -67,730 K
  • 60-Month Beta 0.88
  • Price/Sales 5.21
  • Price/Cash Flow N/A
  • Price/Book 5.62
Trade VSTM with:

Options Overview

Details
  • Implied Volatility 86.75%
  • Historical Volatility 43.89%
  • IV Percentile 15%
  • IV Rank 6.46%
  • IV High 376.60% on 10/29/20
  • IV Low 66.75% on 05/18/21
  • Put/Call Vol Ratio 0.01
  • Today's Volume 767
  • Volume Avg (30-Day) 234
  • Put/Call OI Ratio 0.01
  • Today's Open Interest 15,518
  • Open Int (30-Day) 10,609

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/21
See More
  • Average Estimate -0.09
  • Number of Estimates 1
  • High Estimate -0.09
  • Low Estimate -0.09
  • Prior Year 0.08
  • Growth Rate Est. (year over year) -212.50%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.48 +8.87%
on 08/20/21
2.79 -3.23%
on 08/30/21
-0.02 (-0.74%)
since 08/16/21
3-Month
2.48 +8.87%
on 08/20/21
4.88 -44.67%
on 06/21/21
-1.96 (-42.06%)
since 06/16/21
52-Week
1.14 +136.84%
on 10/28/20
4.93 -45.29%
on 06/14/21
+1.32 (+95.65%)
since 09/16/20

Most Recent Stories

More News
Verastem Oncology to Present at Upcoming Investor Conferences

Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients battling cancer, today announced that management will present virtually at the following...

VSTM : 2.70 (+5.88%)
Verastem Oncology Reports Second Quarter 2021 Financial Results and Highlights Recent Company Progress

--Eliminated Substantially All Outstanding Debt; Expected Cash Runway Until at Least 2024

VSTM : 2.70 (+5.88%)
Verastem Oncology Announces Updated Phase 1/2 FRAME Study Data in Low Grade Serous Ovarian Cancer Selected for a Mini Oral Presentation at the European Society of Medical Oncology Congress 2021

Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients battling cancer, today announced that an abstract detailing updated results from the ongoing...

VSTM : 2.70 (+5.88%)
Axogen, Inc. Appoints John H. Johnson to Board of Directors

Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for damage or discontinuity to peripheral nerves, today announced that John H. Johnson has been appointed...

AXGN : 15.93 (-2.33%)
SBBP : 2.09 (-0.95%)
VSTM : 2.70 (+5.88%)
Verastem Oncology Announces Conversion of Senior Notes Eliminating Substantially All Outstanding Debt

--Cash Runway Expected Until at Least 2024 to Deliver on Current Programs

VSTM : 2.70 (+5.88%)
Verastem Oncology Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Verastem Oncology (Nasdaq:VSTM), a biopharmaceutical company committed to advancing new medicines for patients battling cancer, today announced the grant of options to purchase 16,250 shares of its common...

VSTM : 2.70 (+5.88%)
Verastem Oncology Appoints Paul Bunn, M.D., and Lesley Solomon to Board of Directors

Verastem Oncology (Nasdaq:VSTM), a biopharmaceutical company committed to developing and commercializing new medicines for patients battling cancer, today announced the appointments of Paul Bunn, M.D.,...

VSTM : 2.70 (+5.88%)
Verastem (VSTM) Enters Overbought Territory

Verastem (VSTM) has moved higher as of late, but there could definitely be trouble on the horizon for this company.

VSTM : 2.70 (+5.88%)
Novel Anti-Cancer Drugs Permeate the Marketplace

, /PRNewswire/ -- The cancer therapeutics market is one of the largest segments of the biotechnology industry. According to the National Cancer Institute, roughly 1.8 million people were diagnosed with...

SBFM : 0.1249 (-1.65%)
VSTM : 2.70 (+5.88%)
TRIL : 17.30 (-0.75%)
IMGN : 5.68 (+0.89%)
SRNE : 8.08 (+1.76%)
Thinking about buying stock in Scopus Biopharma, Verastem, Vistagen, PLx Pharma, or Commercial Vehicle?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for SCPS, VSTM, VTGN, PLXP, and CVGI.

CVGI : 9.58 (+4.24%)
SCPS : 5.47 (-4.87%)
VSTM : 2.70 (+5.88%)
PLXP : 17.60 (+3.04%)
VTGN : 2.92 (unch)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Weakening short term outlook on maintaining the current direction.

See More Share

Business Summary

Verastem, Inc., a clinical stage biopharmaceutical company, focuses on discovering and developing drugs to improve outcomes for patients with cancer. Its programs target the focal adhesion kinase (FAK) and the phosphoinositide 3-kinase (PI3K)/mTOR signaling pathways. Its lead FAK inhibitor is defactinib...

See More

Key Turning Points

3rd Resistance Point 2.91
2nd Resistance Point 2.81
1st Resistance Point 2.75
Last Price 2.70
1st Support Level 2.59
2nd Support Level 2.49
3rd Support Level 2.43

See More

52-Week High 4.93
Fibonacci 61.8% 3.49
Fibonacci 50% 3.04
Last Price 2.70
Fibonacci 38.2% 2.59
52-Week Low 1.14

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar